DH · Definitive Healthcare Corp.
$0.64
0.00 (-0.23%)
At close · Aug 14
Market Cap
$68.23M
Shares
106.74M
Definitive Healthcare Corp. Earnings Call Transcripts
Every quarterly earnings call for Definitive Healthcare Corp. (DH) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲33.2%
$57.38M
−$3.02M
'22 Q3
22-11-03
▲30.8%
$60.60M
$9.87M
'22 Q4
23-02-23
▲18.1%
$59.20M
−$12.06M
'23 Q1
23-05-04
▲11.7%
$60.96M
−$8.57M
'23 Q2
23-08-14
▲13.8%
$65.33M
−$171.53M
'23 Q3
23-11-02
▲8.8%
$65.93M
−$10.23M
'23 Q4
24-02-28
▲7.2%
$63.48M
−$9.52M
'24 Q1
24-05-07
▲4.6%
$63.74M
−$213.63M
'24 Q2
24-07-30
▼4%
$62.70M
−$130.90M
'24 Q3
24-11-07
▼5.5%
$62.29M
−$59.08M
'24 Q4
25-02-27
▼6.8%
$59.19M
−$107.23M
'25 Q1
25-05-08
▼4.7%
$60.75M
−$7.55M
'25 Q2
25-08-07
▼4.2%
$60.05M
−$14.84M
'25 Q3
25-11-06
▼1.2%
$61.53M
−$9.31M
'25 Q4
26-02-26
▼5.5%
$55.93M
−$138.62M
'26 Q1
26-05-07
LATEST
▼9.1%
$55.20M
−$5.42M
'26 Q2
26-08-10
Earnings call
FY26 · Q2
2026-08-10
Definitive Healthcare Corp. Q2 FY2026 Earnings Call
Revenue
$55.20M
▼ 9.1% YoY Diluted EPS
$-0.05
Gross margin
73.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Definitive Healthcare Corp. Q1 FY2026 Earnings Call
Positive tone
Diversified and Provider segment growth
Profitability and expense discipline
Revenue decline and top-line pressure
Revenue
$55.93M
▼ 5.5% YoY Diluted EPS
$-1.32
Gross margin
74.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Definitive Healthcare Corp. Q4 FY2025 Earnings Call
Positive tone
Revenue performance and guidance
Customer retention and NDR
Profitability and free cash flow
Revenue
$61.53M*
▼ 1.2% YoY Gross margin
76.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Definitive Healthcare Corp. Q3 FY2025 Earnings Call
Cautious tone
Renewals and retention
Data assets and claims data
Customer wins and enterprise growth
Revenue
$60.05M
▼ 4.2% YoY Diluted EPS
$-0.14
Gross margin
76.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Definitive Healthcare Corp. Q2 FY2025 Earnings Call
Positive tone
Renewal and Retention Improvement
Revenue Decline and Guidance
Innovation and Digital Engagement
Revenue
$60.75M
▼ 4.7% YoY Diluted EPS
$-0.07
Gross margin
76.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Definitive Healthcare Corp. Q1 FY2025 Earnings Call
Positive tone
Profitability and cash flow
Retention/churn improvement
Revenue performance and guidance
Revenue
$59.19M
▼ 6.8% YoY Diluted EPS
$-0.95
Gross margin
73.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Definitive Healthcare Corp. Q4 FY2024 Earnings Call
Positive tone
Guidance and Financial Outlook
Customer Retention / Churn
New Logo Wins / Sales Pipeline
Revenue
$62.29M*
▼ 5.5% YoY Gross margin
76.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Definitive Healthcare Corp. Q3 FY2024 Earnings Call
Balanced tone
Revenue and financial results
Customer churn and retention
Unified platform strategy
Revenue
$62.70M
▼ 4% YoY Diluted EPS
$-1.12
Gross margin
78.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-30
Definitive Healthcare Corp. Q2 FY2024 Earnings Call
Cautious tone
Profitability and margins
Product and platform roadmap
Sales execution and reorganization
Revenue
$63.74M
▲ 4.6% YoY Diluted EPS
$-1.81
Gross margin
79.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Definitive Healthcare Corp. Q1 FY2024 Earnings Call
Cautious tone
Pipeline improvement
Adjusted EBITDA margin expansion and profitability
Tuck-in acquisitions and AI/data science
Revenue
$63.48M
▲ 7.2% YoY Diluted EPS
$-0.08
Gross margin
79.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Definitive Healthcare Corp. Q4 FY2023 Earnings Call
Positive tone
Life sciences end market
Populi acquisition and provider market
Adjusted EBITDA margin and cost actions
Revenue
$65.93M*
▲ 8.8% YoY Gross margin
81.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Definitive Healthcare Corp. Q3 FY2023 Earnings Call
Revenue
$65.33M
▲ 13.8% YoY Diluted EPS
$-1.50
Gross margin
81.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Definitive Healthcare Corp. Q2 FY2023 Earnings Call
Revenue
$60.96M
▲ 11.7% YoY Diluted EPS
$-0.08
Gross margin
81.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Definitive Healthcare Corp. Q1 FY2023 Earnings Call
Revenue
$59.20M
▲ 18.1% YoY Diluted EPS
$-0.11
Gross margin
79.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Definitive Healthcare Corp. Q4 FY2022 Earnings Call
Revenue
$60.60M
▲ 30.8% YoY Diluted EPS
$0.06
Gross margin
83.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Definitive Healthcare Corp. Q3 FY2022 Earnings Call
Revenue
$57.38M
▲ 33.2% YoY Diluted EPS
$-0.03
Gross margin
83.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Definitive Healthcare Corp. Q2 FY2022 Earnings Call
Revenue
$54.55M
▲ 37% YoY Diluted EPS
$-0.06
Gross margin
78.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Definitive Healthcare Corp. Q1 FY2022 Earnings Call
Revenue
$50.12M
▲ 35.7% YoY Diluted EPS
$-0.09
Gross margin
77.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Definitive Healthcare Corp. Q4 FY2021 Earnings Call
Revenue
$46.31M
▲ 37.6% YoY Diluted EPS
$-0.11
Gross margin
76.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-08
Definitive Healthcare Corp. Q3 FY2021 Earnings Call
Revenue
$43.08M
▲ 43.3% YoY Diluted EPS
$-0.09
Gross margin
75.7%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Showing 1–20 of 20 earnings calls
Key facts
CIK
1861795
CUSIP
24477E103
13F (30d)
96 filings
96 filers
Visit website
Investor relations